Global Synthetic Blood Substitutes Market Research Report 2021

1 Synthetic Blood Substitutes Market Overview

• 1.1 Product Overview and Scope of Synthetic Blood Substitutes
• 1.2 Synthetic Blood Substitutes Segment by Product Type
  • 1.2.1 Global Synthetic Blood Substitutes Sales Growth Rate Comparison by Product Type (2021-2027)
  • 1.2.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
  • 1.2.3 Perfluorocarbon (PFCs)
  • 1.2.4 Others
• 1.3 Synthetic Blood Substitutes Segment by Application
  • 1.3.1 Synthetic Blood Substitutes Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cardiovascular Diseases
  • 1.3.3 Anemia
  • 1.3.4 Malignant Neoplasm
  • 1.3.5 Injuries and Trauma
  • 1.3.6 Neonatal Conditions
  • 1.3.7 Maternal Conditions
  • 1.3.8 Organ Transplant
  • 1.3.9 Others
• 1.4 Global Synthetic Blood Substitutes Market Size Estimates and Forecasts
  • 1.4.1 Global Synthetic Blood Substitutes Revenue 2016-2027
  • 1.4.2 Global Synthetic Blood Substitutes Sales 2016-2027
  • 1.4.3 Synthetic Blood Substitutes Market Size by Region: 2016 Versus 2021 Versus 2027

2 Synthetic Blood Substitutes Market Competition by Manufacturers

• 2.1 Global Synthetic Blood Substitutes Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Synthetic Blood Substitutes Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Synthetic Blood Substitutes Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Synthetic Blood Substitutes Manufacturing Sites, Area Served, Product Type
• 2.5 Synthetic Blood Substitutes Market Competitive Situation and Trends
  • 2.5.1 Synthetic Blood Substitutes Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Synthetic Blood Substitutes Players Market Share by Revenue
  • 2.5.3 Global Synthetic Blood Substitutes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Synthetic Blood Substitutes Retrospective Market Scenario by Region

• 3.1 Global Synthetic Blood Substitutes Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Synthetic Blood Substitutes Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Synthetic Blood Substitutes Market Facts & Figures by Country
  • 3.3.1 North America Synthetic Blood Substitutes Sales by Country
  • 3.3.2 North America Synthetic Blood Substitutes Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Synthetic Blood Substitutes Market Facts & Figures by Country
  • 3.4.1 Europe Synthetic Blood Substitutes Sales by Country
  • 3.4.2 Europe Synthetic Blood Substitutes Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Synthetic Blood Substitutes Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Synthetic Blood Substitutes Sales by Region
  • 3.5.2 Asia Pacific Synthetic Blood Substitutes Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Synthetic Blood Substitutes Market Facts & Figures by Country
  • 3.6.1 Latin America Synthetic Blood Substitutes Sales by Country
  • 3.6.2 Latin America Synthetic Blood Substitutes Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Synthetic Blood Substitutes Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Synthetic Blood Substitutes Sales by Country
  • 3.7.2 Middle East and Africa Synthetic Blood Substitutes Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Synthetic Blood Substitutes Historic Market Analysis by Type

• 4.1 Global Synthetic Blood Substitutes Sales Market Share by Type (2016-2021)
• 4.2 Global Synthetic Blood Substitutes Revenue Market Share by Type (2016-2021)
• 4.3 Global Synthetic Blood Substitutes Price by Type (2016-2021)

5 Global Synthetic Blood Substitutes Historic Market Analysis by Application

• 5.1 Global Synthetic Blood Substitutes Sales Market Share by Application (2016-2021)
• 5.2 Global Synthetic Blood Substitutes Revenue Market Share by Application (2016-2021)
• 5.3 Global Synthetic Blood Substitutes Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Hemarina
  • 6.1.1 Hemarina Corporation Information
  • 6.1.2 Hemarina Description and Business Overview
  • 6.1.3 Hemarina Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Hemarina Product Portfolio
  • 6.1.5 Hemarina Recent Developments/Updates
• 6.2 Sagart Corporation
  • 6.2.1 Sagart Corporation Corporation Information
  • 6.2.2 Sagart Corporation Description and Business Overview
  • 6.2.3 Sagart Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Sagart Corporation Product Portfolio
  • 6.2.5 Sagart Corporation Recent Developments/Updates
• 6.3 FLUORO2 Therapeutics
  • 6.3.1 FLUORO2 Therapeutics Corporation Information
  • 6.3.2 FLUORO2 Therapeutics Description and Business Overview
  • 6.3.3 FLUORO2 Therapeutics Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 FLUORO2 Therapeutics Product Portfolio
  • 6.3.5 FLUORO2 Therapeutics Recent Developments/Updates
• 6.4 Biopure Corporation
  • 6.4.1 Biopure Corporation Corporation Information
  • 6.4.2 Biopure Corporation Description and Business Overview
  • 6.4.3 Biopure Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Biopure Corporation Product Portfolio
  • 6.4.5 Biopure Corporation Recent Developments/Updates
• 6.5 Alpha Therapeutic Corporation
  • 6.5.1 Alpha Therapeutic Corporation Corporation Information
  • 6.5.2 Alpha Therapeutic Corporation Description and Business Overview
  • 6.5.3 Alpha Therapeutic Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Alpha Therapeutic Corporation Product Portfolio
  • 6.5.5 Alpha Therapeutic Corporation Recent Developments/Updates
• 6.6 KaloCyte
  • 6.6.1 KaloCyte Corporation Information
  • 6.6.2 KaloCyte Description and Business Overview
  • 6.6.3 KaloCyte Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 KaloCyte Product Portfolio
  • 6.6.5 KaloCyte Recent Developments/Updates
• 6.7 Baxter
  • 6.6.1 Baxter Corporation Information
  • 6.6.2 Baxter Description and Business Overview
  • 6.6.3 Baxter Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Baxter Product Portfolio
  • 6.7.5 Baxter Recent Developments/Updates
• 6.8 Green Cross Corporation
  • 6.8.1 Green Cross Corporation Corporation Information
  • 6.8.2 Green Cross Corporation Description and Business Overview
  • 6.8.3 Green Cross Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Green Cross Corporation Product Portfolio
  • 6.8.5 Green Cross Corporation Recent Developments/Updates
• 6.9 North Field Laboratories
  • 6.9.1 North Field Laboratories Corporation Information
  • 6.9.2 North Field Laboratories Description and Business Overview
  • 6.9.3 North Field Laboratories Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 North Field Laboratories Product Portfolio
  • 6.9.5 North Field Laboratories Recent Developments/Updates
• 6.10 Alliance Pharmaceutical Corporation
  • 6.10.1 Alliance Pharmaceutical Corporation Corporation Information
  • 6.10.2 Alliance Pharmaceutical Corporation Description and Business Overview
  • 6.10.3 Alliance Pharmaceutical Corporation Synthetic Blood Substitutes Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Alliance Pharmaceutical Corporation Product Portfolio
  • 6.10.5 Alliance Pharmaceutical Corporation Recent Developments/Updates

7 Synthetic Blood Substitutes Manufacturing Cost Analysis

• 7.1 Synthetic Blood Substitutes Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Synthetic Blood Substitutes
• 7.4 Synthetic Blood Substitutes Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Synthetic Blood Substitutes Distributors List
• 8.3 Synthetic Blood Substitutes Customers

9 Synthetic Blood Substitutes Market Dynamics

• 9.1 Synthetic Blood Substitutes Industry Trends
• 9.2 Synthetic Blood Substitutes Growth Drivers
• 9.3 Synthetic Blood Substitutes Market Challenges
• 9.4 Synthetic Blood Substitutes Market Restraints

10 Global Market Forecast

• 10.1 Synthetic Blood Substitutes Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Synthetic Blood Substitutes by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Synthetic Blood Substitutes by Type (2022-2027)
• 10.2 Synthetic Blood Substitutes Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Synthetic Blood Substitutes by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Synthetic Blood Substitutes by Application (2022-2027)
• 10.3 Synthetic Blood Substitutes Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Synthetic Blood Substitutes by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Synthetic Blood Substitutes by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List